Canadian application, no grantCanada
Identification of partial agonists of the a2a adenosine receptor
CA 2671940 A1 · Owner: Gilead Sciences, Inc. · Inventors: Gao, Zhenhai; Belardinelli, Luiz; Blackburn, Brent
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for identifying and using partial adenosine, A2A receptor agonists that are useful as adjuncts in myocardiological perfusion imaging.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 23, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 23, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 23, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 23, 2001
GrantedNo grant recorded
Term endedFebruary 23, 2021
Patent numberCA 2671940 A1
Classification (IPC)G01N33/56 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.